GlaxoSmithKline plc (GSKN) — Cash Flow-to-Debt Ratio
GlaxoSmithKline plc (GSKN) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of MX$2.22 Billion could theoretically repay 0% of its total liabilities (MX$45.59 Billion) in one year. Explore GlaxoSmithKline plc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GlaxoSmithKline plc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for GlaxoSmithKline plc across 12 annual periods. Also explore GSKN current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for GlaxoSmithKline plc (2013–2024)
Year-by-year debt coverage analysis for GlaxoSmithKline plc. For market capitalisation and broader financial context, see market cap of GlaxoSmithKline plc.
| Year | CF-to-Debt Ratio | Operating CF (MXN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | MX$6.55 Billion | MX$46.38 Billion | ▲ +19.2% |
| 2023 | 0.12x | MX$5.48 Billion | MX$46.21 Billion | ▼ -19.9% |
| 2022 | 0.15x | MX$7.40 Billion | MX$50.05 Billion | ▲ +7.4% |
| 2021 | 0.14x | MX$7.95 Billion | MX$57.76 Billion | ▼ -2.8% |
| 2020 | 0.14x | MX$8.44 Billion | MX$59.62 Billion | ▲ +8.3% |
| 2019 | 0.13x | MX$8.02 Billion | MX$61.34 Billion | ▼ -15.5% |
| 2018 | 0.15x | MX$8.42 Billion | MX$54.39 Billion | ▲ +18.4% |
| 2017 | 0.13x | MX$6.92 Billion | MX$52.89 Billion | ▲ +8.9% |
| 2016 | 0.12x | MX$6.50 Billion | MX$54.12 Billion | ▲ +108.3% |
| 2015 | 0.06x | MX$2.57 Billion | MX$44.57 Billion | ▼ -60.2% |
| 2014 | 0.14x | MX$5.18 Billion | MX$35.72 Billion | ▼ -31.2% |
| 2013 | 0.21x | MX$7.22 Billion | MX$34.27 Billion | — |